Sign in
4

Changes in Ownership

Arcadia Biosciences, Inc. Filed Acc 0001209191-19-049070

Chief Commercial Officer bought 1,200 shares at $6.48 ($7,776)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reiter Sarah Chief Commercial Officer 2019-09-10 Purchase +1,200 $6.48 $7,776 1,200 D
Open-market purchases · 1,200 sh · avg $6.48 · $7,776
Loading xslF345X03/doc4.xml…